Felix Beuschlein

69.4k total citations · 6 hit papers
428 papers, 13.5k citations indexed

About

Felix Beuschlein is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Felix Beuschlein has authored 428 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Endocrinology, Diabetes and Metabolism, 246 papers in Surgery and 89 papers in Cancer Research. Recurrent topics in Felix Beuschlein's work include Adrenal and Paraganglionic Tumors (229 papers), Hormonal Regulation and Hypertension (215 papers) and Pituitary Gland Disorders and Treatments (111 papers). Felix Beuschlein is often cited by papers focused on Adrenal and Paraganglionic Tumors (229 papers), Hormonal Regulation and Hypertension (215 papers) and Pituitary Gland Disorders and Treatments (111 papers). Felix Beuschlein collaborates with scholars based in Germany, Switzerland and United States. Felix Beuschlein's co-authors include Martín Reincke, Martin Faßnacht, Bruno Allolio, Marcus Quinkler, Martin Bidlingmaier, Stefanie Hahner, Graeme Eisenhofer, Holger S. Willenberg, Mirko Peitzsch and Andrea Oßwald and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Felix Beuschlein

403 papers receiving 13.3k citations

Hit Papers

Evidence for two types of brown adipose tissue in humans 2013 2026 2017 2021 2013 2014 2021 2020 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evidence for two types of brown adipose tissue in humans
    2013 520 citations Felix Beuschlein et al. profile →
  2. Mutations in the deubiquitinase gene USP8 cause Cushing's disease
    2014 405 citations Martín Reincke, Andrea Oßwald et al. profile →
  3. Personalized Management of Pheochromocytoma and Paraganglioma
    2021 200 citations Svenja Nölting, Nicole Bechmann et al. Endocrine Reviews profile →
  4. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗
    2020 180 citations Paolo Mulatero, Silvia Monticone et al. Journal of Hypertension profile →
  5. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
    2023 99 citations Frida Renström, Stefan Aczél et al. Obesity Surgery profile →
  6. GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study
    2024 42 citations Philipp A. Gerber, Felix Beuschlein et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Beuschlein Germany 64 9.0k 7.7k 2.9k 2.4k 1.1k 428 13.5k
Franco Mantero Italy 65 13.8k 1.5× 8.7k 1.1× 1.6k 0.5× 2.3k 1.0× 2.1k 2.0× 372 17.5k
Martin Faßnacht Germany 67 9.7k 1.1× 11.1k 1.4× 7.7k 2.6× 2.2k 0.9× 537 0.5× 416 16.5k
Márta Korbonits United Kingdom 65 7.0k 0.8× 3.7k 0.5× 1.5k 0.5× 3.8k 1.6× 529 0.5× 422 15.5k
Peter Lommer Kristensen Denmark 31 5.1k 0.6× 2.2k 0.3× 2.4k 0.8× 2.9k 1.2× 1.0k 1.0× 114 11.5k
Mansoor Husain Canada 48 4.8k 0.5× 2.6k 0.3× 433 0.1× 4.3k 1.8× 2.5k 2.4× 158 10.9k
Masayoshi Shichiri Japan 55 2.7k 0.3× 2.7k 0.4× 480 0.2× 3.3k 1.4× 2.4k 2.3× 230 10.1k
Richard E. Pratt United States 60 3.1k 0.3× 3.0k 0.4× 843 0.3× 6.6k 2.8× 6.3k 5.9× 169 13.4k
David L. Kleinberg United States 40 5.7k 0.6× 2.1k 0.3× 338 0.1× 1.2k 0.5× 260 0.2× 96 7.5k
Robert C. Smallridge United States 49 5.3k 0.6× 1.3k 0.2× 724 0.2× 2.5k 1.1× 193 0.2× 209 9.1k
Michael E. Mendelsohn United States 58 6.6k 0.7× 2.1k 0.3× 724 0.2× 4.6k 1.9× 3.9k 3.7× 118 16.0k

Countries citing papers authored by Felix Beuschlein

Since Specialization
Citations

This map shows the geographic impact of Felix Beuschlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Beuschlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Beuschlein more than expected).

Fields of papers citing papers by Felix Beuschlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Beuschlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Beuschlein. The network helps show where Felix Beuschlein may publish in the future.

Co-authorship network of co-authors of Felix Beuschlein

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Beuschlein. A scholar is included among the top collaborators of Felix Beuschlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Beuschlein. Felix Beuschlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Güntner, Andreas T., Philipp A. Gerber, Petra S. Dittrich, et al.. (2025). Challenges and opportunities of wearable molecular sensors in endocrinology and metabolism. Nature Reviews Endocrinology. 22(1). 50–60.
2.
Pamporaki, Christina, Ioannis D. Apostolopoulos, Angelos Filippatos, et al.. (2025). Utility of disease probability scores to guide decision-making during screening for phaeochromocytoma and paraganglioma: a machine learning modelling cross sectional study. EClinicalMedicine. 82. 103181–103181. 1 indexed citations
3.
Luca, Edlira, Andrea Abate, Stefan R. Bornstein, et al.. (2024). Human and Murine Cell Lines for Adrenocortical Carcinoma and Pheochromocytoma. SHILAP Revista de lepidopterología. 5(3). 261–276. 1 indexed citations
4.
Gozzi, Noemi, Sanne Kikkert, Giacomo Valle, et al.. (2024). Wearable non-invasive neuroprosthesis for targeted sensory restoration in neuropathy. Nature Communications. 15(1). 10840–10840. 5 indexed citations
5.
Nyírő, Gábor, Zoltán Herold, János Tibor Fekete, et al.. (2024). Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension. 81(12). 2479–2488. 6 indexed citations
6.
Chelbi, Sonia T., Daniel Ackermann, Felix Beuschlein, et al.. (2024). Swiss Salt Study 2, second survey on salt consumption in Switzerland: Main results. 2(2).
7.
Constantinescu, Georgiana, Christina Pamporaki, Mirko Peitzsch, et al.. (2024). Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study. The Journal of Applied Laboratory Medicine. 9(4). 752–766. 5 indexed citations
8.
Constantinescu, Georgiana, Mirko Peitzsch, Hanna Remde, et al.. (2024). Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs. Hypertension. 81(10). 2060–2071. 8 indexed citations
9.
Adolf, Christian, Holger Schneider, Lisa Mueller, et al.. (2023). Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology. 189(6). 611–618. 3 indexed citations
10.
Ernst, Matthias, Felix Beuschlein, René Hage, et al.. (2023). Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis. 22(4). 722–729. 24 indexed citations
11.
Luca, Edlira, Kathrin Zitzmann, Stefan R. Bornstein, et al.. (2023). Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System. Cancers. 15(18). 4601–4601. 2 indexed citations
12.
Friemel, Juliane, Diana Vetter, Kuno Lehmann, et al.. (2023). PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization. Cancers. 15(21). 5199–5199. 2 indexed citations
13.
Renström, Frida, et al.. (2023). Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obesity Surgery. 33(4). 1017–1025. 99 indexed citations breakdown →
14.
Crona, Joakim, et al.. (2022). Targeted Therapies in Pheochromocytoma and Paraganglioma. The Journal of Clinical Endocrinology & Metabolism. 107(11). 2963–2972. 29 indexed citations
15.
Martínez, Eduardo Ribes, et al.. (2022). Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma. Endocrinology. 163(9). 7 indexed citations
16.
Eisenhofer, Graeme, Max Kurlbaum, Mirko Peitzsch, et al.. (2021). The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy. The Journal of Clinical Endocrinology & Metabolism. 107(5). e2027–e2036. 40 indexed citations
17.
Nölting, Svenja, Nicole Bechmann, David Taïeb, et al.. (2021). Personalized Management of Pheochromocytoma and Paraganglioma. Endocrine Reviews. 43(2). 199–239. 200 indexed citations breakdown →
18.
Mulatero, Paolo, Silvia Monticone, Jaap Deinum, et al.. (2020). Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗. Journal of Hypertension. 38(10). 1919–1928. 180 indexed citations breakdown →
19.
Berr, Christina, Mareike R. Stieg, Timo Deutschbein, et al.. (2017). Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry. European Journal of Endocrinology. 176(6). 737–746. 53 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franco Mantero Breakdown of academic impact, for papers by Martin Faßnacht Breakdown of academic impact, for papers by Márta Korbonits Breakdown of academic impact, for papers by Peter Lommer Kristensen Breakdown of academic impact, for papers by Mansoor Husain Breakdown of academic impact, for papers by Masayoshi Shichiri Breakdown of academic impact, for papers by Richard E. Pratt Breakdown of academic impact, for papers by David L. Kleinberg Breakdown of academic impact, for papers by Robert C. Smallridge Breakdown of academic impact, for papers by Michael E. Mendelsohn
Rankless by CCL
2026